Which diabetes drug wins? new study pits dapagliflozin vs empagliflozin
Disease control
Not yet recruiting
This study compares two common diabetes drugs, dapagliflozin and empagliflozin, to see which works better for lowering blood sugar and weight in people with type 2 diabetes and a high body mass index. About 112 adults will take one of the two drugs for six months. Researchers wil…
Phase: PHASE4 • Sponsor: Bhavya Bhavya, MD • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC